Duhn Therapeutics
PrivateLast Round
Strategic
Oct 23, 2024
Company Overview
Duhn Therapeutics operates in Healthcare & Life Sciences and is based in Dijon. Its latest recorded funding round was a Strategic round in October 2024.
Duhn Therapeutics is a biotechnology company that develops lipid-based cancer immunotherapies to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Duhn Therapeutics Comparables
Compare Duhn Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BiPER Therapeutics | 76% | |
| Stimunity | 72% | |
| Boehringer Ingelheim | 70% |
For institutional investors. Book with your work email.
Duhn Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Duhn Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Landmark BioVentures AG | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
Monthly visitors grew 190% MoM, reaching 1.3K.
- Mar 5, 2026
Monthly visitors grew 121% MoM, reaching 1.8K.
For institutional investors. Book with your work email.
Duhn Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Duhn Therapeutics's valuation, stock price, and market status.
Is Duhn Therapeutics a public or private company?
Duhn Therapeutics is a private company.
What is the current stock price of Duhn Therapeutics?
Duhn Therapeutics is a private company, so its shares have no public market price. Caplight tracks Duhn Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Duhn Therapeutics worth (valuation)?
Valuation information for Duhn Therapeutics is not publicly available.
Can I buy Duhn Therapeutics stock?
Duhn Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Duhn Therapeutics's last funding round?
Duhn Therapeutics's most recent funding round was Strategic on October 23, 2024.
Who are the main investors in Duhn Therapeutics?
Key investors in Duhn Therapeutics include Landmark BioVentures AG.
Will Duhn Therapeutics IPO soon?
No public IPO plans have been announced for Duhn Therapeutics.
How can I track Duhn Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Duhn Therapeutics's shares on secondary markets.